SCHEMBL24218436

SCHEMBL24218436

CN(C)c1ccc(/N=N/c2ccc(C(=O)NCCN)cc2)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.56
NPC1 O15118 2/20 0.56
MEN1 O00255 2/20 0.56
KDM4E B2RXH2 2/20 0.56
MAPT P10636 1/20 0.56
MAPK1 P28482 1/20 0.56
RAB9A P51151 1/20 0.56
POLB P06746 1/20 0.56
HDAC1 Q13547 11/20 0.55
HDAC6 Q9UBN7 9/20 0.55
HDAC10 Q969S8 8/20 0.55
HDAC8 Q9BY41 8/20 0.55
HDAC2 Q92769 7/20 0.55
HDAC3 O15379 7/20 0.55
HDAC4 P56524 4/20 0.55
HDAC7 Q8WUI4 4/20 0.55
HDAC11 Q96DB2 4/20 0.55
HDAC9 Q9UKV0 4/20 0.55
HDAC5 Q9UQL6 4/20 0.55
CYP1A2 P05177 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28555102 1.00 KMT2A (0.56) KMT2ANPC1MEN1KDM4EMAPT
SCHEMBL22793229 0.92 HDAC1 (0.59) KMT2ANPC1MEN1KDM4EMAPT
SCHEMBL18874959 0.87 NPC1 (0.58) KMT2ANPC1MEN1KDM4EMAPT
SCHEMBL10103983 0.84 NPC1 (0.55) KMT2ANPC1MEN1KDM4EMAPT
SCHEMBL19939430 0.84 HDAC1 (0.62) KMT2ANPC1MEN1KDM4EMAPT
SCHEMBL13104839 0.83 HDAC1 (0.63) KMT2ANPC1MEN1KDM4EMAPT
SCHEMBL8161491 0.82 HDAC1 (0.65) KMT2ANPC1MEN1KDM4EMAPT
SCHEMBL18874948 0.82 HDAC1 (0.54) KMT2ANPC1MEN1KDM4EMAPT
SCHEMBL16127281 0.82 HDAC1 (0.68) KMT2AKDM4EHDAC1HDAC6HDAC10
SCHEMBL12531524 0.82 KMT2A (0.49) KMT2ANPC1MEN1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220025254-A1 Complexes and Ligands THE GENERAL HOSPITAL CORPORATION 2022-01-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220025254-A1 Complexes and Ligands BID, CLTB, NECTIN4 KMT2A 4577/4885NPC1 657/4885MEN1 2204/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.